Medication - Sterile Compounding - Using Primary and Secondary Engineering Controls with Testing/Certification Failures
Can we still use our Primary Engineering Control if it fails its testing/certification ?
Any examples are for illustrative purposes only.
It is up to the organization to determine whether or not the compounding space is acceptable to continue producing sterile compounded medication products. Factors should include the pathogenicity of the organism grown in the positive growth viable sample; complexity level of the compounded product; any known/potential associated hospital acquired infections; and guidance from the infection control practitioner.
It is up to the organization to determine whether or not the compounding space is acceptable to continue producing sterile compounded medication products. Factors should include the pathogenicity of the organism grown in the positive growth viable sample; complexity level of the compounded product; any known/potential associated hospital acquired infections; and guidance from the infection control practitioner.
Manual:
Home Care
Chapter:
Medication Management MM
First published date: January 23, 2018
This Standards FAQ was first published on this date.
This page was last updated on June 07, 2024
with update notes of: Editorial changes only
Types of changes and an explanation of change type:
Editorial changes only: Format changes only. No changes to content. |
Review only, FAQ is current: Periodic review completed, no changes to content. |
Reflects new or updated requirements: Changes represent new or revised requirements.